Literature DB >> 17112572

alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats.

Richard A Glennon1, Tatiana Bondareva, Richard Young.   

Abstract

alpha-Ethyltryptamine (etryptamine, alpha-ET) is a drug of abuse that first appeared on the clandestine market in the mid-1980s. Its pharmacological actions are poorly understood. In this investigation, it is reported for the first time that alpha-ET serves as a training drug in drug discrimination studies. Male Sprague-Dawley rats were trained to discriminate (30-min pretreatment time) 2.5 mg/kg of alpha-ET (ED(50)=1.3 mg/kg) from saline vehicle using a standard two-lever operant paradigm and a VI-15s schedule of reinforcement for appetitive reward. Once established, the alpha-ET stimulus was shown to have an onset to action of 30 min and a duration of effect of at least 4 h. In tests of stimulus generalization (substitution), the alpha-ET stimulus generalized to S(-)alpha-ET (ED(50)=1.6 mg/kg) and R(+)alpha-ET (ED(50)=1.3 mg/kg). Tests of stimulus generalization were also conducted with prototypical phenylisopropylamines: (+)amphetamine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), and N-methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA). The alpha-ET stimulus generalized to DOM (ED(50)=0.4 mg/kg) and PMMA (ED(50)=0.7 mg/kg), but only partially generalized (ca. 40% maximal drug-appropriate responding) to (+)amphetamine. The results suggest that alpha-ET produces a complex stimulus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112572      PMCID: PMC2565776          DOI: 10.1016/j.pbb.2006.09.014

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  26 in total

1.  ENZYME INHIBITORY ACTIVITY OF 3-(2-AMINOBUTYL)INDOLE DERIVATIVES.

Authors:  J B HESTER; M E GREIG; W C ANTHONY; R V HEINZELMAN; J SZMUSZKOVICZ
Journal:  J Med Chem       Date:  1964-05       Impact factor: 7.446

2.  CENTRAL STIMULANT ACTIONS OF ALPHA-ALKYL SUBSTITUTED TRYPTAMINES IN MICE.

Authors:  A W LESSIN; R F LONG; M W PARKES
Journal:  Br J Pharmacol Chemother       Date:  1965-02

3.  The effect of three tryptamine derivatives on serotonin metabolism in vitro and in vivo.

Authors:  M E GREIG; R A WALK; A J GIBBONS
Journal:  J Pharmacol Exp Ther       Date:  1959-10       Impact factor: 4.030

4.  The use of psychic energizers in general practice.

Authors:  G A DE JONG
Journal:  J Neuropsychiatr       Date:  1961-02

5.  The pharmacology of etryptamine.

Authors:  M E GREIG; P H SEAY; W A FREYBURGER
Journal:  J Neuropsychiatr       Date:  1961-02

6.  A new and safer monoamine oxidase inhibitor.

Authors:  T R ROBIE
Journal:  J Neuropsychiatr       Date:  1961-02

7.  Effects in normal man of alpha-methyltryptamine and alpha-ethyltryptamine.

Authors:  H B MURPHREE; R H DIPPY; E H JENNEY; C C PFEIFFER
Journal:  Clin Pharmacol Ther       Date:  1961 Nov-Dec       Impact factor: 6.875

8.  S(+)- and R(-)N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: effect of cocaine.

Authors:  Tatiana Bondareva; Anna Wesołowska; Małgorzata Dukat; Mase Lee; Richard Young; Richard A Glennon
Journal:  Pharmacol Biochem Behav       Date:  2005-12-07       Impact factor: 3.533

9.  Discriminative stimulus properties of alpha-ethyltryptamine optical isomers.

Authors:  S S Hong; R Young; R A Glennon
Journal:  Pharmacol Biochem Behav       Date:  2001 Oct-Nov       Impact factor: 3.533

10.  Actions of some analogues of tryptamine on the isolated rat uterus and on the isolated rat fundus strip preparations.

Authors:  R B BARLOW; I KHAN
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  4 in total

1.  The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.

Authors:  Richard A Glennon
Journal:  J Med Chem       Date:  2017-03-15       Impact factor: 7.446

2.  Alpha-ethyltryptamines as dual dopamine-serotonin releasers.

Authors:  Bruce E Blough; Antonio Landavazo; John S Partilla; Ann M Decker; Kevin M Page; Michael H Baumann; Richard B Rothman
Journal:  Bioorg Med Chem Lett       Date:  2014-07-29       Impact factor: 2.823

Review 3.  Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy.

Authors:  Hans Emanuel Oeri
Journal:  J Psychopharmacol       Date:  2020-09-10       Impact factor: 4.153

Review 4.  Toxicology and Analysis of Psychoactive Tryptamines.

Authors:  Sara Malaca; Alfredo Fabrizio Lo Faro; Alice Tamborra; Simona Pichini; Francesco Paolo Busardò; Marilyn A Huestis
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.